Announced Sat, 17 May · 15:41 IST

A meeting of the Board of Directors is scheduled to be held on wednesday,28th May 2025 at 03:00pm to consider and recommend final dividend for the year ended 31st March 2025.

Corporate Actions View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sandu Pharmaceuticals has informed BSE that its Board of Directors will meet on Wednesday, 28th May 2025 at 3:00 PM to consider and recommend a final dividend for the financial year ended 31st March 2025. The intimation is filed under Regulation 29(1)(e) of SEBI (LODR) Regulations, 2015. No details on the quantum of dividend, dividend yield, or record date have been provided in this notice. The outcome of the board meeting will be disclosed after 28th May 2025.

Likely market impact

This is a routine pre-announcement of a board meeting to consider a dividend — it does not by itself confirm any dividend, amount, or yield. Shareholders should await the board's decision on 28th May 2025 for the actual dividend recommendation, after which the stock may see modest positive sentiment depending on the declared amount.